- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.02. | After losing its CMO last summer, CytomX Therapeutics finally nabs a replacement | ||
| 04.02. | After bagging $200M-plus in 2019, Passage Bio guns for $125M IPO | ||
| 04.02. | A16z unveils $750M fund to bankroll startups at intersection of tech, medicine | ||
| 03.02. | FDA clears Olympus' duodenoscope with additional cleaning tools | ||
| 03.02. | Insmed's inflammatory lung disease drug makes the grade in phase 2 | ||
| 03.02. | Abbott to test its heart device against lifetime blood thinners for reducing stroke risk | ||
| 03.02. | Fighting Alzheimer's by cutting off amyloid at its source | ||
| 03.02. | Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs | ||
| 03.02. | Gilead climbs as coronavirus drug shows efficacy, starts trial | ||
| 03.02. | Boston Pharmaceuticals nabs Novartis veteran as new CMO | ||
| 03.02. | GSK makes adjuvant available to coronavirus vaccine project | ||
| 03.02. | Building a portable concussion detector using infrared lasers | ||
| 31.01. | University of Pennsylvania researchers nab grant for CAR-T prostate cancer test | ||
| 31.01. | 'We can do better': BIO's first breakdown of diversity in member companies | ||
| 31.01. | California court orders Johnson & Johnson to pay $344M over pelvic mesh marketing claims | ||
| 31.01. | Immuno-oncology combination for melanoma using Nektar drug boosts cell therapy in mice | ||
| 31.01. | Chutes & Ladders-Ex-Takeda exec Ivarsson joins Moderna as CDO | ||
| 31.01. | Improving CAR-T therapy for cancer by regulating 2 proteins | ||
| 31.01. | GeNeuro raises €17.5M for multiple sclerosis clinical trial | ||
| 31.01. | Mammoth Biosciences nabs $45M for CRISPR drugs, diagnostics work | ||
| 31.01. | Vertex drops VX-961 to continue search for perfect pain drug | ||
| 30.01. | Abbott nets first CE mark for transcatheter mitral valve replacement | ||
| 30.01. | Microsoft launches five-year, $40M AI initiative in global health | ||
| 30.01. | Eli Lilly cuts three cancer drugs amid Q4 clear-out | ||
| 30.01. | Ex-Shire/Takeda clinical trials chief Ivarsson lands at Moderna |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
